| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ... Hepatology 49 (6), 1877-1887, 2009 | 1774 | 2009 |
| European consensus conference on faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ... Gut 66 (4), 569-580, 2017 | 1251 | 2017 |
| Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection G Cammarota, L Masucci, G Ianiro, S Bibbò, G Dinoi, G Costamagna, ... Alimentary pharmacology & therapeutics 41 (9), 835-843, 2015 | 726 | 2015 |
| Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review G Cammarota, G Ianiro, A Gasbarrini Journal of clinical gastroenterology 48 (8), 693-702, 2014 | 615 | 2014 |
| Effect of Different Probiotic Preparations on Anti-Helicobacter PyloriTherapy-Related Side Effects: A Parallel Group, Triple Blind, Placebo-Controlled Study F Cremonini, S Di Caro, M Covino, A Armuzzi, M Gabrielli, L Santarelli, ... Official journal of the American College of Gastroenterology| ACG 97 (11 …, 2002 | 550 | 2002 |
| Association of Virulent Helicobacter pylori Strains With Ischemic Heart Disease V Pasceri, G Cammarota, G Patti, L Cuoco, A Gasbarrini, RL Grillo, ... Circulation 97 (17), 1675-1679, 1998 | 521 | 1998 |
| The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy A Armuzzi, F Cremonini, F Bartolozzi, F Canducci, M Candelli, V Ojetti, ... Alimentary pharmacology & therapeutics 15 (2), 163-169, 2001 | 493 | 2001 |
| The role of diet on gut microbiota composition. S Bibbo, G Ianiro, V Giorgio, F Scaldaferri, L Masucci, A Gasbarrini, ... European Review for Medical & Pharmacological Sciences 20 (22), 2016 | 465 | 2016 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 459 | 2019 |
| Probiotics in prevention and treatment of obesity: a critical view N Kobyliak, C Conte, G Cammarota, AP Haley, I Styriak, L Gaspar, ... Nutrition & metabolism 13, 1-13, 2016 | 417 | 2016 |
| A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates F Canducci, A Armuzzi, F Cremonini, G Cammarota, F Bartolozzi, P Pola, ... Alimentary pharmacology & therapeutics 14 (12), 1625-1629, 2000 | 401 | 2000 |
| Management and treatment of lactose malabsorption M Montalto, V Curigliano, L Santoro, M Vastola, G Cammarota, R Manna, ... World journal of gastroenterology: WJG 12 (2), 187, 2006 | 374 | 2006 |
| Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota W Fusco, MB Lorenzo, M Cintoni, S Porcari, E Rinninella, F Kaitsas, ... Nutrients 15 (9), 2211, 2023 | 335 | 2023 |
| Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility F Scaldaferri, V Gerardi, LR Lopetuso, F Del Zompo, F Mangiola, ... BioMed research international 2013 (1), 435268, 2013 | 317 | 2013 |
| Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study A Armuzzi, F Cremonini, V Ojetti, F Bartolozzi, F Canducci, M Candelli, ... Digestion 63 (1), 1-7, 2001 | 301 | 2001 |
| Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth G Nucera, M Gabrielli, A Lupascu, EC Lauritano, A Santoliquido, ... Alimentary pharmacology & therapeutics 21 (11), 1391-1395, 2005 | 280 | 2005 |
| Gut microbiome, big data and machine learning to promote precision medicine for cancer G Cammarota, G Ianiro, A Ahern, C Carbone, A Temko, MJ Claesson, ... Nature reviews gastroenterology & hepatology 17 (10), 635-648, 2020 | 277 | 2020 |
| Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial EC Nista, M Candelli, F Cremonini, IA Cazzato, MA Zocco, F Franceschi, ... Alimentary pharmacology & therapeutics 20 (10), 1181-1188, 2004 | 275 | 2004 |
| Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome A Lupascu, M Gabrielli, EC Lauritano, E Scarpellini, A Santoliquido, ... Alimentary pharmacology & therapeutics 22 (11‐12), 1157-1160, 2005 | 254 | 2005 |
| The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy G Cammarota, G Ianiro, R Cianci, S Bibbò, A Gasbarrini, D Currò Pharmacology & therapeutics 149, 191-212, 2015 | 246 | 2015 |
